Publication dates

Therapeutic Vaccine Industry, October 2014 Market Research & Statistics

You might be interested in: vaccine, drug, biotech, more »

1-10 of about 300 reports for Therapeutic Vaccine

Drug Sales Demand in the US

  • Hbm New Drug Approval Report 2013
  • July 2013
    21 pages
  • Drug  

  • United States  

View report >

Microbix - Annual Report, 2014

  • Microbix' Virology Revenue Grows 24% in third Quarter, Company R...
  • January 2014
    4 pages
  • Biotechnology  

  • Europe  

    United States  

View report >

Medical Analysis in the UK

  • Strength and Opportunity 2013
  • January 2013
    64 pages
  • Medical  

    Industrial Biot...  

  • United Kingdom  

    Europe  

    World  

View report >

Medical Analysis in the UK

  • Strength and Opportunity 2013
  • January 2013
    60 pages
  • Medical  

    Industrial Biot...  

  • United Kingdom  

    Europe  

    World  

View report >

Analyst Report, January 2014

  • Small-cap Research
  • January 2014
    8 pages
  • World  

    United States  

View report >

Pathology Description in Israel

  • Israeli Biopharma Industry Report
  • September 2014
    62 pages
  • Pathology  

    Cancer  

  • Israel  

    Asia  

    World  

View report >

Antibody market trends in the US

  • Ebola & Marburg Virus Vaccine Elisa Kits, Recombinant Proteins, ...
  • January 2014
    6 pages
  • Antibody  

    Vaccine  

  • United States  

View report >

Pathology Description in Europe

  • Background Paper 6.5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

Medicine Markets in the US

  • Full Color
  • January 2013
    78 pages
  • Medicine  

  • United States  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >
35 reports for Therapeutic Vaccine

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 4 650)

AVAX Technologies, Inc. (AVXT) - Strategic SWOT Analysis Review

AVAX Technologies, Inc. (AVXT) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary AVAX Technologies, Inc. (AVAX) is a biotechnology company. The company develops and commercializes individualized vaccine therapies and technologies used in the treatment of oncology-related diseases. ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.